@ProfLowell#fin2209 CGC's cash cycle is 197.5 - 33.65 = 163.85 days, meaning the firm tends to 1) hold on to their inventory and 2) they allow their customers to take a long time to pay. However, in the US, cannabis sales at dispensaries must take place with either cash or debit
@ProfLowell#fin2209 CGC's Receivables Period for FY2022 was 50.91 days, implying that the company's operating cycle is 197.50 days. This shows that the firm requires more cash than the average firm to maintain its operations.
@ProfLowell#fin2209 According to Morningstar, CGC's inventory turnover for FY2022 was 2.49, meaning that their inventory period was approx. 146.59 days. It takes nearly half a year for the company to acquire and then sell inventory.
Wishing all of our American employees, partners and followers a very Happy Thanksgiving! ๐
Throughout November, our Canopy team members proudly volunteered and supported local community food banks in New York, Chicago and Denver in the lead-up to Thanksgiving ๐
A new poll from @PewResearch reveals that 88% of Americans believe in #cannabis legalization for either medical or recreational use, demonstrating the continued rise in public support for U.S. reform.
Read the full study results here: https://t.co/m4aoWL7ukI
@ProfLowell#fin2209 from its IPO, $CGC has held the largest market cap in the cannabis industry. The garnered hype around the stock's public listing did not quite keep up with the North American legalization timeline that many expected. CGC is set to experience a 2nd growth in
@ProfLowell#fin2209 $CGC's IPO was a first listing price of $3.08USD on the TSX. When CGC listed on NYSE in 2018, the stock began trading around $29.00, an 841% increase in price over 4 years.
@ProfLowell#fin2209 $CGC was the first cannabis stock to be approved to be listed on a North American public exchange, when it listed on the Toronto Stock Exchange's Venture List in 2014. CGC then listed on the NYSE in May 2018 as the first cannabis producer on the NYSE.
CGC will also acquire a minority stake in TerrAscend, a leading North American cannabis operator with vertically integrated operations and a presence in PA, NJ, MI, and CA as well as licensed cultivation and processing operations in MD
@ProfLowell#fin2209 as of 10/25, CGC announced a strategic move to accelerate the company's entry into the US cannabis market, by the creation of a US-domiciled holding company under Canopy USA, LLC - assisting in the mjrty acquisition of 3 THC companies.
@ProfLowell#fin2209 as investors continue to spectate a bear market rally for the end of 2022, this gives opportunity for $CGC to make gains in the market - Q2 2023 earnings (announced 11/09) will significant impact the performance of the stock for the rest of the year.
@ProfLowell#fin2209 CGC's (5Y monthly) beta is 2.02, showing that risk-inclined investors should consider investing in $CGC for potential high returns. Yahoo Finance predicts a bullish pattern in CGC's stock price currently.
@ProfLowell#fin2209 CGC's free cash flow in Q1 FY2023 was recorded as an outflow of $143M, representing a 23% decrease in outflow YoY - this reflects a decrease in CapEx + completion of ongoing infrastructure projects.
@ProfLowell#fin2209 CGC's operating cash flow increased by 11.77% from FY 2021, showing positive growth and trajectory towards efficient financial management.
@ProfLowell#fin2209 According to Yahoo Finance, CGC's operating cash flow for 2022 was -$520.55M, implying that the company has had significant gridlock in day-to-day operating activities. The company's divesture in certain company extensions will hopefully reduce this.
@ProfLowell#fin2209 CGC does not have an available P/E ratio on any financial analysis sites, but currently has a price-to-book ratio of 0.95 and a price-to-sales ratio of 2.59. Compared to competitor Cronos Group Inc, CGC has a higher P/B but lower P/S ratio.
@ProfLowell#fin2209 Yahoo Finance estimates that EPS will further decrease to -4.03 in FY2024 - this means that current investors will be weary of holding their positions in the company L-T.
@ProfLowell#fin2209 CGC's basic EPS is -0.77 (source: Yahoo Finance), showing that investors are currently losing 0.77 per dollar invested in the company. CGC has struggled with growth in recent years.